ADMA Biologics, Inc. (ADMA)
8.46
-1.62
(-16.07%)
USD |
NASDAQ |
May 07, 16:00
8.47
+0.01
(+0.12%)
After-Hours: 04:04
ADMA Biologics Research and Development Expense (Annual) : 4.762M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Inovio Pharmaceuticals, Inc. | 52.79M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Liquidia Corp. | 38.45M |
| Ligand Pharmaceuticals, Inc. | 81.18M |